Key considerations for differentiated antiretroviral therapy delivery for specific populations: children, adolescents, pregnant and breastfeeding women and key populations
Overview
In 2016, WHO published consolidated guidelines on the use of antiretroviral (ARV) drugs for treating and preventing HIV infection. As part of this revision, WHO recognized that, as ART is scaled up and countries adopt the “treat all” policy, ART services will need to be differentiated to provide adapted packages of care to people living with HIV with varied clinical needs.
At the time the 2016 WHO consolidated ARV guidelines were developed, there was limited evidence and experience around how these criteria should be applied to pregnant and breastfeeding women, children and adolescents and members of key populations. Since then, appreciation has been growing that these types of clients may also benefit from models of care specifically for clinically stable clients.
This document outlines the rationale for and features of differentiated ART delivery for clinically stable clients in these populations.
Related topics
- HIV service delivery
- Treatment and care
- Treatment of children living with HIV
- Men who have sex with men
- People in prisons and other closed settings
- Sex workers
- Transgender people
- People who inject drugs
Related publications
- Publications on HIV service delivery
- Publications on treatment and care
- Toolkits, manuals, guides, reports and policy briefs
- Publications: Treatment of children living with HIV
- Men who have sex with men and transgender people publications
- Publications on prisons and other closed settings
- Publications on sex work
- Publications on transgender people
- Publications on people who inject drugs